🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary Objective * To evaluate the safety and tolerability of co-administ...
Status
Completed
Location
Faculty of Tropical Medicine
Start Date
2015-10
Trial ID
NCT02568098
Treatments Being Tested
Intermittent preventive treatment (IPT) offers a way of preventing malaria ...
Status
Completed
Location
Medical Research Council Laboratories,
Start Date
2007-08
Trial ID
NCT00561899
Treatments Being Tested
This will be a single-centre, 5-cohort, randomized open-label, parallel-gro...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-07-31
Trial ID
NCT02184637
Treatments Being Tested
Emerging resistance to artemisinins and their partner drugs severely threat...
Status
Withdrawn
Location
Multiple Locations
Start Date
2015-06
Trial ID
NCT02461186
In line with the global and regional efforts towards malaria elimination, a...
Status
Completed
Location
Multiple Locations
Start Date
2015-11
Trial ID
NCT02914145
Treatments Being Tested
The study was designed to assess the effect of food on the extent and rate ...
Status
Completed
Location
CMAX, a division of IDT Australia Limited
Start Date
2010-03
Trial ID
NCT01222962
Treatments Being Tested
There is a need for paediatric formulations that permit accurate dosing and...
Status
Completed
Location
Centre Muraz
Start Date
2013-11
Trial ID
NCT01992900
Treatments Being Tested
The observed changes of P. falciparum sensitivity to artemisinin lead to th...
Status
Completed
Location
Hospital of Tropical Diseases, Faculty of Tropical Medicine, Mahidol University
Start Date
2012-05
Trial ID
NCT01552330
Treatments Being Tested
WHO recommends the use of artemisinin-based combination therapies (ACTs) in...
Status
Unknown
Location
Nouna Research Centre
Start Date
2013-09
Trial ID
NCT02199951
Treatments Being Tested
Tafenoquine (TQ) is an 8-aminoquinoline anti-malarial drug which is in deve...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-04-08
Trial ID
NCT02802501